Search research articles
Contact Us
Filters
Showing results (21-30 of 585) with videos related to
Page
of 59
Sort By:
Drugs
|
October 16, 2013
Optimal sequencing of anti-HER2 therapy throughout the continuum of HER2-positive breast cancer: evidence and clinical considerations
Nadia Harbeck, Rachel Wuerstlein
Expert Review of Anticancer Therapy
|
June 27, 2017
The safety and efficacy of palbociclib in the treatment of metastatic breast cancer
Johannes Ettl, Nadia Harbeck
Breast (Edinburgh, Scotland)
|
July 2, 2017
Neoadjuvant therapy for triple negative and HER2-positive early breast cancer
Nadia Harbeck, Oleg Gluz
Breast Care (Basel, Switzerland)
|
May 8, 2014
Cutting-edge therapy concepts - cure metastatic breast cancer?
Christoph Thomssen, Nadia Harbeck
Breast Care (Basel, Switzerland)
|
July 23, 2011
Update 2010 of the German AGO Recommendations for the Diagnosis and Treatment of Early and Metastatic Breast Cancer - Chapter B: Prevention, Early Detection, Lifestyle, Premalignant Lesions, DCIS, Recurrent and Metastatic Breast Cancer
Christoph Thomssen, Nadia Harbeck
Nature Reviews. Clinical Oncology
|
January 16, 2019
Truly personalized therapy - an end to the era of one size fits all
Nadia Harbeck, Rachel Wuerstlein
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2012
Lost in translation? Estrogen receptor status and endocrine responsiveness in breast cancer
Nadia Harbeck, Achim Rody
The Oncologist
|
December 9, 2010
A new look at node-negative breast cancer
Nadia Harbeck, Christoph Thomssen
Reviews on Recent Clinical Trials
|
February 7, 2017
Neoadjuvant Therapy for HER2-positive Breast Cancer
Rachel Wuerstlein, Nadia Harbeck
Chirurgia (Bucharest, Romania : 1990)
|
December 30, 2021
Treatment Landscape of Ductal Carcinoma In Situ
Anca Chelariu-Raicu, Nadia Harbeck
Page
of 59
Search research articles
Search
Showing results (21-30 of 585) with videos related to
Sort By:
Page
of 59
Drugs
|
October 16, 2013
Optimal sequencing of anti-HER2 therapy throughout the continuum of HER2-positive breast cancer: evidence and clinical considerations
Nadia Harbeck, Rachel Wuerstlein
Expert Review of Anticancer Therapy
|
June 27, 2017
The safety and efficacy of palbociclib in the treatment of metastatic breast cancer
Johannes Ettl, Nadia Harbeck
Breast (Edinburgh, Scotland)
|
July 2, 2017
Neoadjuvant therapy for triple negative and HER2-positive early breast cancer
Nadia Harbeck, Oleg Gluz
Breast Care (Basel, Switzerland)
|
May 8, 2014
Cutting-edge therapy concepts - cure metastatic breast cancer?
Christoph Thomssen, Nadia Harbeck
Breast Care (Basel, Switzerland)
|
July 23, 2011
Update 2010 of the German AGO Recommendations for the Diagnosis and Treatment of Early and Metastatic Breast Cancer - Chapter B: Prevention, Early Detection, Lifestyle, Premalignant Lesions, DCIS, Recurrent and Metastatic Breast Cancer
Christoph Thomssen, Nadia Harbeck
Nature Reviews. Clinical Oncology
|
January 16, 2019
Truly personalized therapy - an end to the era of one size fits all
Nadia Harbeck, Rachel Wuerstlein
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2012
Lost in translation? Estrogen receptor status and endocrine responsiveness in breast cancer
Nadia Harbeck, Achim Rody
The Oncologist
|
December 9, 2010
A new look at node-negative breast cancer
Nadia Harbeck, Christoph Thomssen
Reviews on Recent Clinical Trials
|
February 7, 2017
Neoadjuvant Therapy for HER2-positive Breast Cancer
Rachel Wuerstlein, Nadia Harbeck
Chirurgia (Bucharest, Romania : 1990)
|
December 30, 2021
Treatment Landscape of Ductal Carcinoma In Situ
Anca Chelariu-Raicu, Nadia Harbeck
Page
of 59